Temazepam
FDA-approved product (capsule, oral), marketed as Restoril, Temaz, Temazepam.
- Registered studies
- 12
- Lab records
- 0
- Pathogens at ≥40%
- 2 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBL- WHO therapeutic group
- Benzodiazepine derivatives
- FDA pharmacologic class
- Benzodiazepine FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against M. tuberculosis and MRSA. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA52.3% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli30.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae25.9% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis53.4% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
12registered studies name this medicine, for any condition. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Temazepam with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Efficacy of Wholetones® 2Sleep Music on Health and Sleep Behaviors of Healthy Adults With Insomnia Symptoms
NCT03928301 · start 2019-01-15
Registered record
- Registry ID
- NCT03928301
- Conditions
- Insomnia; Sleeplessness
- Interventions
- Wholetones Music; Classical Music
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-01-15
- Completion
- 2019-03-12
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInsomnia; SleeplessnessInterventionWholetones Music; Classical MusicPhaseNot applicableRegistry statusCompletedBrainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence
NCT03423017 · start 2018-05-24
Registered record
- Registry ID
- NCT03423017
- Conditions
- Pierre Robin Sequence; Brainstem Dysfunction
- Interventions
- Recording of data; Recording of data
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-05-24
- Completion
- 2023-03-23
- Enrolment
- 113
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPierre Robin Sequence; Brainstem DysfunctionInterventionRecording of data; Recording of dataPhaseNot applicableRegistry statusCompletedA Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)
NCT04679103 · start 2018-05-03
Registered record
- Registry ID
- NCT04679103
- Conditions
- Paroxysmal Nocturnal Hemoglobinuria
- Interventions
- Eculizumab (JSC GENERIUM, Russia)
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2018-05-03
- Completion
- 2020-04-20
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionParoxysmal Nocturnal HemoglobinuriaInterventionEculizumab (JSC GENERIUM, Russia)PhasePhase 3Registry statusCompletedNon Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations
NCT02558738 · start 2015-06-22
Registered record
- Registry ID
- NCT02558738
- Conditions
- Pruritus; Dermatitis; Otitis Externa
- Interventions
- ear spray
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2015-06-22
- Completion
- 2015-09
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPruritus; Dermatitis; Otitis ExternaInterventionear sprayPhaseNot recordedRegistry statusCompletedTrial to Compare Femoral Nerve Block With Local Anaesthetic Injection for Post-operative Pain After Knee Replacement.
NCT02288923 · start 2015-03
Registered record
- Registry ID
- NCT02288923
- Conditions
- Arthritis Knee
- Interventions
- Femoral nerve block; Local Infiltration Analgesia; Sub arachnoid analgesia; Sedation or general anaesthesia; Pre-medication; Intra-operative medication; Post-operative analgesia - morphine; Post-operative analgesia - ibuprofen and paracetamol; Regular anti emetics
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-03
- Completion
- 2018-07-01
- Enrolment
- 199
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionArthritis KneeInterventionFemoral nerve block; Local Infiltration Analgesia; Sub arachnoid analgesia; Sedation or general anaesthesia +5 morePhaseNot applicableRegistry statusCompletedPharmacovigilance in Gerontopsychiatric Patients
NCT02374567 · start 2015-01
Registered record
- Registry ID
- NCT02374567
- Conditions
- Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety Disorders
- Interventions
- Phenobarbital; Phenytoin; Carbamazepine; Oxcarbazepine; Valproic Acid; Lamotrigine; Topiramate; Gabapentin; Levetiracetam; Pregabalin; Lacosamide; Clonazepam; Biperiden; Levomepromazine; Fluphenazine; Perphenazine; Perazine; Thioridazine; Haloperidol; Melperone; Pipamperone; Bromperidol; Benperidol; Sertindole; Ziprasidone; Flupentixol; Chlorprothixene; Zuclopenthixol; Fluspirilene; Pimozide; Clozapine; Olanzapine; Quetiapine; Sulpiride; Tiapride; Amisulpride; Prothipendyl; Risperidone; Aripiprazole; Paliperidone; Diazepam; Oxazepam; Lorazepam; Bromazepam; Clobazam; Alprazolam; Hydroxyzine; Buspirone; Chloral Hydrate; Flurazepam; Nitrazepam; Triazolam; Lormetazepam; Temazepam; Midazolam; Brotizolam; Zopiclone; Zolpidem; Zaleplon; Melatonin; Clomethiazole; Diphenhydramine; Promethazine; Imipramine; Clomipramine; Opipramol; Trimipramine; Amitriptyline; Nortriptyline; Doxepin; Maprotiline; Amitriptyline oxide; Fluoxetine; Citalopram; Paroxetine; Sertraline; Fluvoxamine; Escitalopram; Tran
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Terminated
- Start
- 2015-01
- Completion
- 2017-06-28
- Enrolment
- 407
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDementia; Depression; Schizophrenia; Psychosomatic Disorders +1 moreInterventionPhenobarbital; Phenytoin; Carbamazepine; Oxcarbazepine +75 morePhasePhase 3Registry statusTerminatedEffects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 · start 2014-04
Registered record
- Registry ID
- NCT02033707
- Conditions
- Healthy
- Interventions
- Hallucinogens and psychoactive substances
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2014-04
- Completion
- 2019-02
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthyInterventionHallucinogens and psychoactive substancesPhasePhase 1Registry statusCompletedComparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude
NCT01519544 · start 2012-03
Registered record
- Registry ID
- NCT01519544
- Conditions
- High-altitude Sleep Disturbance
- Interventions
- Temazepam; Acetazolamide
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2012-03
- Completion
- 2015-03
- Enrolment
- 34
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHigh-altitude Sleep DisturbanceInterventionTemazepam; AcetazolamidePhaseNot applicableRegistry statusCompletedEfficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia
NCT02153788 · start 2009-09
Registered record
- Registry ID
- NCT02153788
- Conditions
- Insomnia
- Interventions
- Temazepam; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-09
- Completion
- Not recorded
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInsomniaInterventionTemazepam; PlaceboPhasePhase 4Registry statusCompletedStudy to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women
NCT00940550 · start 2009-07
Registered record
- Registry ID
- NCT00940550
- Conditions
- Insomnia
- Interventions
- Prolonged-release melatonin; Temazepam; Zolpidem; Placebo to match melatonin, zolpidem and temazepam
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2009-07
- Completion
- 2009-08
- Enrolment
- 16
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInsomniaInterventionProlonged-release melatonin; Temazepam; Zolpidem; Placebo to match melatonin, zolpidem and temazepamPhasePhase 1Registry statusCompletedThe Treatment of Insomnia in Patients With HIV Disease
NCT00465972 · start 2007-03
Registered record
- Registry ID
- NCT00465972
- Conditions
- HIV Infections; Insomnia
- Interventions
- Doxepin; Temazepam; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2007-03
- Completion
- 2010-08
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHIV Infections; InsomniaInterventionDoxepin; Temazepam; PlaceboPhasePhase 4Registry statusCompletedEffects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease
NCT00245661 · start 2005-10
Registered record
- Registry ID
- NCT00245661
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Temazepam
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2005-10
- Completion
- 2007-08
- Enrolment
- 14
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Obstructive Pulmonary DiseaseInterventionTemazepamPhasePhase 3Registry statusCompleted